Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine
PHASE2
The proposed study V72P9E1 is an Extension Study of V72P9. The objectives o...
Status
Completed
Location
Oxford Vaccine Group, Center for Clinical Vaccinology and Tropical Medicine, Churchill Hospital
Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine
PHASE2
The proposed study V72P6E1 is an Extension Study of V72P6 (NCT00381615). Th...
Status
Completed
Location
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital